Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Shares of Chico’s FAS, Inc. (CHS) Are Down on Thursday

Page 1 of 2

Chico’s FAS, Inc. (NYSE:CHS)’s shares have retreated by more than 3% out of the gate after the company’s first-quarter results came in below expectations. For the period, Chico’s FAS posted a net income of $0.25 per share on sales of $643 million, missing estimates by $0.06 per share and $24.86 million. Sales declined by 7.9% year-over-year due to a 4.2% drop in comparable sales and 15 net store closures. The gross margin was 40.8% versus 42.4% in last year’s first quarter. The company bought $36.6 million worth of its own shares back in the quarter, however. Management is trying to right the ship by increasing efficiency and reducing costs.

Is Chico’s FAS, Inc. (NYSE:CHS) a healthy stock for your portfolio? The best stock pickers are getting more optimistic and the number of long hedge fund positions improved by three in recent months. In this way, CHS was in the equity portfolios of 25 hedge funds tracked by Insider Monkey at the end of the first quarter of 2016. However, the level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as TESARO Inc (NASDAQ:TSRO), Express, Inc. (NYSE:EXPR), and Diplomat Pharmacy Inc (NYSE:DPLO) to gather more data points.

Follow Chicos Fas Inc (NYSE:CHS)
Trade (NYSE:CHS) Now!

Today there are numerous signals investors employ to size up stocks. A duo of the most under-the-radar signals are hedge fund and insider trading activity. We have shown that, historically, those who follow the top picks of the top fund managers can trounce their index-focused peers by a superb margin (see the details here).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Blue Harbour Group, managed by Clifton S. Robbins, holds the most valuable position in Chico’s FAS, Inc. (NYSE:CHS). Blue Harbour Group has a $54.2 million position in the stock, comprising 1.8% of its 13F portfolio. Coming in second is Jim Simons’ Renaissance Technologies, which holds a $51.6 million position; 0.1% of its 13F portfolio is allocated to the stock. Some other peers with similar optimism consist of Ken Griffin’s Citadel Investment Group, David E. Shaw’s D E Shaw and Cliff Asness’s AQR Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!